Non Small Cell Lung Cancer
Conditions
Keywords
Chinese, T1 non-small cell lung cancer, Lymph metastases
Brief summary
The real-world observational study was designed to explore the odd factors of lymph metastases in the patients with T1 non-small cell lung cancer, the effects of clinical characteristics on lymph metastases, and compare the differences in lymph metastases in the subgroups.
Detailed description
The trial is a multi-centre, real-world non-interventional observational study. In the study, the patients with T1 non-small cell lung cancer enrolled in clinics from 2015 to 2017 were included via a retrospectively review method and the study data on patient demographic/tumor biological characteristics, and clinical treatments were collected to explore the clinical odd factors of lymph metastases, evaluate the effects of clinical characteristics on lymph metastases, and compare the differences in lymph metastases in the subgroups.
Interventions
PROCEDURESurgeries
Surgeries
Sponsors
Jiangsu Cancer Institute & Hospital
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Patients who received surgeries from 2015 to 2017; * Pathologically diagnosed patients with T1 non-small cell lung cancer;
Exclusion criteria
\- Patients with tumor treatments (including chemotherapies, radiotherapies, biological therapies, intervention therapies)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Percentage of the patients with lymph metastases | 2015 - 2017 | Percentages of the patients with lymph metastases categorised by patient demographic and tumor biological characteristics |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Percentages of N0/N1/N2/N3 patients | 2015 - 2017 | Percentages of N0/N1/N2/N3 patients in the target population |
Other
| Measure | Time frame | Description |
|---|---|---|
| Percentage of N2 patients with lymph nodes | 2015 - 2017 | Percentages of N2 patients with lymph nodes in N2 population |
| Percentage of patients with lymph metastases categorised by tumor baseline characteristics | 2015 - 2017 | Percentage of patients with lymph metastases categorised by tumor baseline characteristics |
| Number of lymph nodes in N2 patients | 2015 - 2017 | Number of lymph nodes in N2 patients categorised by tumor baseline characteristics |
| Percentage of patients with N2 skip metastases | 2015 - 2017 | Percentage of patients with N2 skip metastases categorised by tumor baseline characteristics |
Countries
China
Outcome results
None listed